These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24069197)

  • 21. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model.
    Godin D; Ivan E; Johnson C; Magid R; Galis ZS
    Circulation; 2000 Dec; 102(23):2861-6. PubMed ID: 11104745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice.
    Choi ET; Collins ET; Marine LA; Uberti MG; Uchida H; Leidenfrost JE; Khan MF; Boc KP; Abendschein DR; Parks WC
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1020-5. PubMed ID: 15746435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine.
    Kim DE; Kim JY; Schellingerhout D; Shon SM; Jeong SW; Kim EJ; Kim WK
    Mol Imaging; 2009; 8(5):291-301. PubMed ID: 19796606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque.
    Shon SM; Park JH; Nahrendorf M; Schellingerhout D; Kim JY; Kang BT; Jeong SW; Kim EJ; Ryu JH; Kim K; Kwon IC; Lee DK; Lee MM; Kim DE
    Atherosclerosis; 2011 May; 216(1):67-73. PubMed ID: 21334624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed flow induces systemic changes in metabolites in mouse plasma: a metabolomics study using ApoE⁻/⁻ mice with partial carotid ligation.
    Go YM; Kim CW; Walker DI; Kang DW; Kumar S; Orr M; Uppal K; Quyyumi AA; Jo H; Jones DP
    Am J Physiol Regul Integr Comp Physiol; 2015 Jan; 308(1):R62-72. PubMed ID: 25377480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice.
    Schönberger T; Siegel-Axel D; Bussl R; Richter S; Judenhofer MS; Haubner R; Reischl G; Klingel K; Münch G; Seizer P; Pichler BJ; Gawaz M
    Cardiovasc Res; 2008 Oct; 80(1):131-7. PubMed ID: 18566102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions.
    Ivan E; Khatri JJ; Johnson C; Magid R; Godin D; Nandi S; Lessner S; Galis ZS
    Circulation; 2002 Jun; 105(22):2686-91. PubMed ID: 12045177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice.
    Nachtigal P; Pospisilova N; Vecerova L; Micuda S; Brcakova E; Pospechova K; Semecky V
    J Atheroscler Thromb; 2009 Jun; 16(3):265-74. PubMed ID: 19556713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo.
    Wang Z; Deng G; Zhang Z; Huang H; Zhao Y
    Nucl Med Commun; 2017 Apr; 38(4):299-305. PubMed ID: 28234785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.
    Maguire JJ; Wiley KE; Kuc RE; Stoneman VE; Bennett MR; Davenport AP
    Exp Biol Med (Maywood); 2006 Jun; 231(6):806-12. PubMed ID: 16741003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular remodeling in ApoE-deficient mice: diet dependent modulation after carotid ligation.
    Eschert H; Sindermann JR; Scheld HH; Breithardt G; Weissen-Plenz G
    Atherosclerosis; 2009 May; 204(1):96-104. PubMed ID: 18848322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis.
    Nam D; Ni CW; Rezvan A; Suo J; Budzyn K; Llanos A; Harrison D; Giddens D; Jo H
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1535-43. PubMed ID: 19684185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.
    Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
    Blood; 2000 Dec; 96(13):4212-5. PubMed ID: 11110693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.